BioMerieux Q1 Sales Down 3.9% On Organic Basis; Revises 2026 Guidance

AI Briefing

• – BioMerieux reports Q1 sales down 3.9% on organic basis
• – Company revises 2026 guidance due to sales decline
• – Consolidated sales fall 10.4% year-over-year